Pandemic Preparedness Archives - Page 2 of 3 - EMEA

This site provides INTERCEPT product information for International audiences .

Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System

Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System

by jaycornell | May 5, 2025

Prof. Salwa Ibrahim Hindawi King Abdulaziz University Jeddah, Saudi Arabia

Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System

Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System

by jaycornell | May 5, 2025

Prof. Salwa Ibrahim Hindawi King Abdulaziz University Jeddah, Saudi Arabia

Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System

Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System

by jaycornell | May 5, 2025

Prof. Salwa Ibrahim Hindawi King Abdulaziz University Jeddah, Saudi Arabia

Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System

Blood safety during the SARS-CoV-2 pandemic and beyond: the impact of pathogen inactivation with the INTERCEPT Blood System

by jaycornell | May 5, 2025

Prof. Salwa Ibrahim Hindawi King Abdulaziz University Jeddah, Saudi Arabia

How can we guarantee the supply of blood products to patients?

How can we guarantee the supply of blood products to patients?

by jaycornell | May 5, 2025

Priv-Doz. Dr. med. Ulrich Kalus Charité Berlin, Germany

« Older Entries

Next Entries »